NEW DELHI: In a major development, UK’s Covid-19 vaccine has shown similar strong immune response in healthy older adults -aged 56 years and above- to those seen in people between 18 to 55 years, according to findings from a phase-2 trial. The Oxford Covid-19 vaccine has collaborated with Indian drug maker—Serum Institute of India (SII) for which phase 2 clinical trials are being conducted in India also. The findings of the study have been published in the leading medical journal ‘Lancet’.
Delhi Congress president Devender Yadav, accompanied by Jharkhand Minister for Panchayati Raj Dipika Pandey Singh,…
The relationship between gut microbes, hormones, and dietary preferences is a fascinating area of study…
AI systems like ChatGPT have been linked to environmental concerns, with reports showing their significant…
Rabi Lamichhane, RSP chief and ex-home minister, secures bail in the Swarnalakshmi Cooperative fraud case…
Metformin, the widely prescribed drug for managing type 2 diabetes, has recently gained attention for…
California wildfires leave destruction in their wake, with Stanford experts warning of the underestimated dangers…